Congenital hyperinsulinism of infancy is the commonest cause of persistent and recurrent hypoglycaemia in the neonatal and infancy period. It is a heterogeneous disorder with respect to clinical presentation, histology, molecular biology and genetics. The biochemical profile is one of hypoketotic, hypofattyacidemic hypoglycemia. To prevent permanent brain damage from hypoglycemia, the treatment of infants with congenital hyperinsulinism must be prompt and aggressive. The drugs used in the medical therapy for congenital hyperinsulinism are diazoxide, octreotide, glucagon and nifedipine.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
congenital hyperinsulinism
16
hyperinsulinism infancy
8
medications treatment
4
treatment hypoglycemia
4
congenital
4
hypoglycemia congenital
4
hyperinsulinism
4
infancy congenital
4
infancy commonest
4
commonest persistent
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!